webinar register page

Topic

RedChip Investor Group Call with Zomedica Inc. (NYSE American: ZOM)

Description

Zomedica is revolutionizing veterinary health care with a focus on addressing unmet needs through its expanding product portfolio of innovative diagnostics and medical devices designed to improve pet health as well as productivity and practice profitability for veterinarians. With modest cash burn and a strong balance sheet, including $158.5 million cash, cash equivalents, and available-for-sale securities as of September 30, 2022, Zomedica is well-positioned to fund both organic growth and acquisitions.

Recording Duration

00:44:00

* Required information

Speakers

Larry Heaton

Chief Executive Officer @Zomedica

Larry has more than 35 years of executive leadership and operations experience from the therapeutic, medical device and biotechnology industries, with an extensive focus on business and product development and commercialization at both large-cap and early-stage medical device companies. Most recently, Larry was President, Chief Executive Officer and Director of Flowonix, Inc., a privately held company marketing implantable drug-delivery systems for the management of pain and spasticity. Prior to that, he was President, Chief Executive Officer and Director of Cardiox Corporation, a privately held company that developed and marketed drug-device combination products for the structural heart and liver diagnostics markets.

Time Zone:

Your Information
Send to
Message preview	Hi there, You are invited to a Zoom webinar. When: Mar 21, 2023 04:15 PM Eastern Time (US and Canada) Topic: RedChip Investor Group Call with Zomedica Inc. (NYSE American: ZOM) Register in advance for this webinar: https://redchip.zoom.us/webinar/register/WN_bV-HQba0RduH1cFE4knulg After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Larry Heaton (Chief Executive Officer @Zomedica) Larry has more than 35 years of executive leadership and operations experience from the therapeutic, medical device and biotechnology industries, with an extensive focus on business and product development and commercialization at both large-cap and early-stage medical device companies. Most recently, Larry was President, Chief Executive Officer and Director of Flowonix, Inc., a privately held company marketing implantable drug-delivery systems for the management of pain and spasticity. Prior to that, he was President, Chief Executive Officer and Director of Cardiox Corporation, a privately held company that developed and marketed drug-device combination products for the structural heart and liver diagnostics markets.

webinar register page

The webinar has ended

Register to watch this recording on-demand

Speakers

webinar register page

The webinar has ended

Register to watch this recording on-demand

Speakers

Share via Email

Switch Time Zone

Upcoming Meetings